Don't want ads? Subscribe or login now.

PharMerica Must Face State FCA Claims, Whistleblowers Say

By Dani Kass · October 5, 2017, 3:36 PM EDT

Two whistleblowers accusing PharMerica Inc. of accepting kickbacks from drugmaker Organon USA Inc. have asked a Massachusetts federal court to revive claims dismissed in 2012, arguing claims under various state False...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

United States of America et al v. Organon USA Inc et al

Case Number

1:07-cv-12153

Court

Massachusetts

Nature of Suit

Other Statutory Actions

Date Filed

November 16, 2007

Recent Articles By Dani

July 24, 2024
Newman Facing 2nd Suspension For 'Continuing Misconduct'
July 11, 2024
Vidal Says USPTO Has Improved Patent, TM Application Speed
June 25, 2024
Breaking IP Barriers: Q&A With Harrity's Elaine Spector
April 28, 2023
Philips Loses Trade Secret Trial While Getting DMCA Damages
April 26, 2022
Orrin Hatch's IP Influence Goes Far Beyond Generic Drugs
December 20, 2021
AbbVie Urges ITC To Block Humira Rival Over Trade Secrets
May 07, 2021
Fed. Circ. Says 'Vexatious' Litigant Can't Sue Raytheon, Intel
January 20, 2021
Levandowski's Journey From Google To Trump Pardon
November 19, 2020
Fed. Circ. Says Ex-Employer Can't Take IP Under Calif. Law
September 22, 2020
ITC Will Review Allergan's Win In Botox Trade Secrets Case